Product approval process to be expedited

The new product approval process, which has been delayed due to the recent generic drugs' bioequivalence test data fabrication, may be facilitated by a newly formed task force team, according to the Korea Food and Drug Administration.

In a meeting of people with the Korea Pharmaceuticals Manufacturers Association, the KFDA said that it would work out measures to support domestic pharmaceutic...